INDIANAPOLIS — Indianapolis-based Eli Lilly and Company announced nearly $2 billion in manufacturing investments in Ireland on Thursday.
The pharmaceutical company said $1 billion of that investment will come in the form of expansion of its Limerick, Ireland, manufacturing site to "increase production of biologic active ingredients, including those for its recently approved treatment for early Alzheimer's disease."
Another $800 million will go toward the expansion of a facility in Kinsale, Ireland, which just last year began making medicines "to meet demand for Lilly's latest diabetes and obesity treatments."
In a press release, Lilly said it has committed more than $20 billion since 2020 to acquire, build and expand manufacturing facilities in the United States and Europe.
"These investments will boost the production of some of our medicines, helping millions of people with diabetes, obesity and Alzheimer's disease live the healthiest lives possible," said Edgardo Hernandez, executive vice president and president of Lilly Manufacturing Operations.